Weekly Intelligence · 7 articles
Vet Industry Intel: May 17 – May 23, 2026
High-signal veterinary industry stories triangulated from multiple sources, scored for relevance, and grouped by event type.
Regulatory & Policy
Liavium-CA1 Receives FDA Conditional Approval, Redefining Canine Neuropathic Pain Care
Liavium-CA1 received conditional approval from the FDA for the treatment of canine neuropathic pain, marking a significant development in veterinary pain management.
Liavium-CA1 · FDA
FDA approves oral drug to manage both noise aversion and separation anxiety in dogs - American Animal Hospital Association
The U.S. Food and Drug Administration approved an oral medication for treating noise aversion and separation anxiety in dogs, as reported by the American Animal Hospital Association.
FDA · AAHA
FDA grants conditional approval to targeted therapy for canine Chiari-like malformation and syringomyelia
The FDA has granted conditional approval to a targeted therapy for canine Chiari-like malformation and syringomyelia.
FDA · DVM360
FDA Approval Of Tessie Puts Orion’s Animal Health Potential In Focus
The FDA has granted approval for Tessie, bringing positive attention to Orion's animal health portfolio and market potential.
FDA · Orion
FDA approves cosyntropin injection for use in canines
The FDA has approved cosyntropin injection for use in canines.
FDA · DVM360
Approved by FDA: Precision Fermentation Animal Protein in Pet Food
The FDA has approved precision fermentation animal protein for use in pet food, marking a regulatory milestone for alternative ingredients in the veterinary and pet nutrition space.
FDA
Products & Technology
Dechra Announces FDA Approval of CosACTHen® (cosyntropin injection), the First and Only Cosyntropin Approved Specifically for Canine Patients
Dechra announced FDA approval for CosACTHen (cosyntropin injection), making it the first and only cosyntropin approved specifically for canine patients.
Dechra · FDA · BioSpace